Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia
NCT ID: NCT02582450
Last Updated: 2015-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
70 participants
OBSERVATIONAL
2015-09-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.
NCT02197611
Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia
NCT02581735
Multidisciplinary Evaluation of Patients With Hemophilia
NCT02198430
Transcultural Multidisciplinary Evaluation of Patients With Hemophili
NCT02199639
Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
NCT02396862
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with haemophilia
Sample of patients with haemophilia over 18 years of age that will participate in piloting of reliability and validity of the Spanish version of the Veritas-Pro questionnaire.
Patients with haemophilia
Piloting of reliability and validity of the Spanish version of the Veritas-Pro questionnaire.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patients with haemophilia
Piloting of reliability and validity of the Spanish version of the Veritas-Pro questionnaire.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have previously signed the informed consent document
Exclusion Criteria
* Patients with cognitive impairment, or oral or written understanding
13 Years
65 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtep Inc.
INDUSTRY
Real Fundación Victoria Eugenia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rubén Cuesta-Barriuso, PhD
Role: PRINCIPAL_INVESTIGATOR
Real Fundación Victoria Eugenia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Real Fundación Victoria Eugenia
Madrid, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Veritas-Validation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.